Biopharmaceuticals are rapidly becoming more popular and in recent years have increased from just one, to currently seven of the top 10 drugs. Biopharmaceuticals are proteins and peptides, such as monoclonal antibodies, that are genetically engineered from living cells. The size of these molecules typically fall in the range of 2 to 2,000 kDa. Compared to small molecule pharmaceuticals, biopharmaceuticals have more complex structures and more reactive groups which often lead to lower stability and chemical properties that are easily modified. As a result, the quantitation identification, heterogeneity, impurity content and activity of each batch of target biopharmaceuticals must be thoroughly investigated before release. Due to the complexities of proteins, there is a need for powerful analytical techniques for their characterization, among which capillary liquid chromatography (LC) is one of the most important.
Transferring from established LC methods to micro- and nano-flow capillary LC is a simple procedure
if you follow these guidelines. The mobile phase flow rate must be significantly reduced; other separation conditions (i.e., stationary phase, temperature, mobile phase components and gradient program) remain nearly the same. If the ratio between column length (L) and particle size (dp) is kept within +50% and -25% (as referenced in the United States Pharmacopeia guidelines), then transferring the method should start with adjusting the mobile phase flow rate to keep the linear velocity unchanged. More specifically, flow rate should be scaled according to the change in cross- sectional area of the column, which is proportional to the square of the ratio of the column diameters.
This brief application note demonstrates the use of hand-portable capillary HPLC by the Axcend
Focus LC for intact protein analysis. Specifically, the separation of five test proteins in the range of 5.8 to 45 kDa is shown using reversed phase (RP) conditions. Other protein samples can be analyzed using the Axcend Focus LC merely by adapting established conventional high performance LC methods to the capillary column format.
Time(min) |
Composition B (%) |
0 |
5 |
1 |
30 |
6 |
40 |
14 |
60 |
15 |
95 |
19 |
95 |
Instrumentation: Axcend Focus LC w/UV Detector at 275 nm wavelength
Column: CoAnn C4, 1.7 μm FPP, 300 A, 100mm
Mobile Phase A: 0.1% TFA in water
Mobile Phase B: 0.1% in acetonitrile
Flow Rate: 1.25 uL/min
Injection Detail: 0.2 uL
Sample concentration: 0.25 mg/mL carbonic anhydrase, myoglobin, human insulin, ovalbumin each and 0.1 mg/mL cytochrome C mixture in water
UV detection wavelength: 275 nm
Column temperature: 22° C
Analyte |
MW (kDa) |
RT (min) |
RT %RSD* |
Tailing factor |
Half height peak width (min) |
Cytochrome C |
12.3 |
5.70 |
1.92 |
1.06 |
0.11 |
Insulin |
5.8 |
9.35 |
1.14 |
0.93 |
0.17 |
Myoglobin |
16.7 |
10.17 |
0.70 |
1.67 |
0.13 |
Carbonic Anhydrase |
30 |
10.67 |
0.39 |
1.28 |
0.16 |
Ovalbumin |
45 |
12.89 |
0.85 |
0.68 |
0.21 |
(*n = 6)